Latvia Passes Law Restricting Tobacco Sales to Minors and Flavored E-cigarettes

Regulations by { "type": "", "title": "", "logo": "", "description": "", "auth": "", "seo_url": "" }

Jan.15.2024

Latvia Passes Law Restricting Tobacco Sales to Minors and Flavored E-cigarettes

Latvia's parliament passes bill banning tobacco sales to those under 20, extending to e-cigarettes and herbal smoking products, effective from January 1, 2025.

According to a report by the Belarus news agency "Reform," the Latvian parliament has passed a bill that prohibits individuals under the age of 20 from smoking, purchasing, or selling tobacco products. This restriction will also apply to tobacco substitutes, herbal smoking products, electronic smoking devices, and refill containers. The ban is set to be implemented starting from January 1, 2025.

Currently, Latvia permits the sale of tobacco products to individuals aged 18 and above.

The proposed amendment to the law also prohibits the sale of flavored e-cigarettes and tobacco alternatives, except for tobacco flavor. These restrictions will also come into effect on January 1, 2025.

References:

[1] В Латвии поднимают возрастной ценз для продажи сигарет

Also Read:

[1] Latvia Imposes Fines for Minors' Possession of E-cigarettes

[2] Latvia to Increase Taxes on Tobacco and E-cigarettes

[3] Increasing Consumption Taxes on Tobacco and Alcohol in Latvia

#Europe #Traditional tobacco #Legislation #Open system e-cigarettes #Latvia #E-cigarette #E-cigarettes and Tobacco #Flavored tobacco and nicotine products #Flavored tobacco #E-cigarettes with Flavors

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Alan Zhao: What Altria’s on! PLUS Authorization Really Signals About FDA PMTA Enforcement

In this in-depth commentary for 2Firsts, Alan Zhao examines what Altria’s on! PLUS authorization really signals about FDA PMTA enforcement. Beyond the headline approval, FDA’s language, process design and product choices offer rare insight into how nicotine pouch regulation is taking shape—and what it means for industry compliance, in one of the earliest expert reads of the decision.

Regulations

Dec.20 by { "username": "", "position": "", "avatar": "", "auth": "", "seo_url": "" }

Altria CEO Billy Gifford to Retire; Sal Mancuso Named Successor

Altria Group, Inc. (NYSE: MO) announced that CEO Billy Gifford will retire at the conclusion of the 2026 Annual Meeting of Shareholders on May 14, 2026, after more than 30 years with the company. The Board of Directors has elected Salvatore (Sal) Mancuso, Altria’s current Executive Vice President and CFO, to succeed him as CEO.

Dec.12 by { "username": "", "position": "", "avatar": "", "auth": "", "seo_url": "" }

Philip Morris and R.J. Reynolds Face Trial Over Woman’s Lung Cancer Death in Massachusetts

According to Law360, the family of Maria Petruzziello has taken Philip Morris and R.J. Reynolds to trial in Massachusetts, alleging the companies are responsible for her 2019 lung cancer death after decades of smoking. Plaintiffs argue her experience mirrors many smokers, while the defense points to her years-long cessation and personal choice.

Dec.03 by { "username": "", "position": "", "avatar": "", "auth": "", "seo_url": "" }

Argentine province of Santa Fe passes bill expanding smoking regulations to include e-cigarettes and heated tobacco products